Drug interaction classified as: antagonism
Source: DDInter
Long-acting insulin analogue · Antidiabetic agent
Insulin degludec is a modified insulin with one amino acid deleted (threonine at B30) and conjugated to hexadecanedioic acid. When injected subcutaneously, it forms multihexameric complexes and binds to albumin, which together slow its absorption and extend its action for prolonged basal insulin coverage.
Drug interaction classified as: antagonism
Source: DDInter
Drug interaction classified as: antagonism
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team